MedPath

The effect of topical piroxicam in the treatment of uremic pruritus

Phase 3
Completed
Conditions
remic pruritus.
Pruritus
Registration Number
IRCT20191106045356N18
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Patients undergoing hemodialysis more than 3 times a month
Insensitivity to piroxicam
Patients with chronic uremic pruritus
Absence of pregnancy and breastfeeding

Exclusion Criteria

Patients with underlying skin disease
Allergic to Piroxicam
Pregnancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
remic pruritus. Timepoint: ?Before intervention and 7, 14 days after intervention. Method of measurement: Pruritus questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath